The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia
Abstract
The study's objective was to identify HPA 1a–negative women and to offer them an intervention program aimed to reduce morbidity and mortality of neonatal alloimmune thrombocytopenia (NAIT). HPA 1 typing was performed in 100 448 pregnant women. The HPA 1a–negative women were screened for anti–HPA 1a. In immunized women, delivery was performed by Cesarean section 2 to 4 weeks prior to term, with platelets from HPA 1a–negative donors reserved for immediate transfusion if petechiae were present and/or if platelet count was less than 35 × 109/L. Of the women screened, 2.1% were HPA 1a negative, and anti–HPA 1a was detected in 10.6% of these. One hundred seventy pregnancies were managed according to the intervention program, resulting in 161 HPA 1a–positive children. Of these, 55 had severe thrombocytopenia (< 50 × 109/L), including 2 with intracranial hemorrhage (ICH). One woman with a twin pregnancy missed the follow-up and had one stillborn and one severely thrombocytopenic live child. In 15 previous prospective studies (136 814 women) there were 51 cases of severe NAIT (3 intrauterine deaths and 7 with ICH). Acknowledging the limitation of comparing with historic controls, implementation of our screening and intervention program seemed to reduce the number of cases of severe NAIT-related complications from 10 of 51 to 3 of 57.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Center for Biotechnology Information
Benson, D., Boguski, M., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,126
KIEFEL, V., Santoso, S., Weisheit, M., & Mueller‐Eckhardt, C. (1987) · Blood · doi:10.1182/blood.v70.6.1722.1722 · Cited by 924
348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Mueller-Eckhardt, C., Grubert, A., Weisheit, M., Mueller-Eckhardt, G., Kiefel, V., Kroll, H., Schmidt, S., & Santoso, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91733-9 · Cited by 644
Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
Burrows, R. F., & Kelton, J. G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292005 · Cited by 535
Williamson, L. M., Hackett, G., Rennie, J., Palmer, C. R., Maciver, C., Hadfield, R., Hughes, D., Jobson, S., & Ouwehand, W. H. (1998) · Blood · doi:10.1182/blood.v92.7.2280 · Cited by 449
CULTIVATING LEUKÆMIC LYMPHOCYTES
Moore, W., Gillespie, L., & Dolimpio, D. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90833-7 · Cited by 424
Frequency of Immune Thrombocytopenia in Newborns: A Prospective Study
Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I., Tchernia, G., & the Immune Thrombocytopenia Working Group (1997) · Blood · doi:10.1182/blood.v89.12.4402 · Cited by 299
Maternal Morbidity Associated With Vaginal Versus Cesarean Delivery
Burrows, L. J., Meyn, L. A., & Weber, A. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000124568.71597.ce · Cited by 280
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
Zimmerman, S. A., Schultz, W. H., Burgett, S., Mortier, N. A., & Ware, R. E. (2007) · Blood · doi:10.1182/blood-2006-11-057893 · Cited by 217
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Ciurea, S. O., Merchant, D., Mahmud, N., Ishii, T., Zhao, Y., Hu, W., Bruno, E., Barosi, G., Xu, M., & Hoffman, R. (2007) · Blood · doi:10.1182/blood-2006-12-064626 · Cited by 213
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Bakchoul, T., Greinacher, A., Sachs, U. J., Krautwurst, A., Renz, H., Harb, H., Bein, G., Newman, P. J., & Santoso, S. (2013) · Blood · doi:10.1182/blood-2012-11-468561 · Cited by 54
Metadata
- Authors
- Kjeldsen-Kragh, J., Killie, M. K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Øian, P., Dahl, L. B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Grønn, M., Skogen, B., & Husebekk, A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-08-01
- Volume
- 110
- Issue
- 3
- Pages
- 833-839
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2044052575
- Cited by
- 272
- References
- 15
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. https://app.cochat.ai/papers/10.1182/blood-2006-08-040121
- The paper
- Kjeldsen-Kragh, J., Killie, M. K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Øian, P., Dahl, L. B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Grønn, M., Skogen, B., & Husebekk, A. (2007). A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood. https://doi.org/10.1182/blood-2006-08-040121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.